2022 annual financial data
Autolus Therapeutics 2022 Operating margin
Direct answer
Operating margin was -2,306.96%.
Operating income was -142,893,000 USD and net income was -148,839,000 USD.
Operating cash flow was -112,308,000 USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,194,000 USD
- Operating income
- -142,893,000 USD
- Net income
- -148,839,000 USD
- Operating cash flow
- -112,308,000 USD